Mankind Pharma Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 (Listing Regulations)
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has submitted a regulatory intimation to the stock exchange under Regulation 30 of the SEBI Listing Regulations. This is a standard compliance filing that companies use to disclose material events or information to the stock exchanges and shareholders. The actual content or specific subject matter of the intimation is not included in the headline provided, so the precise nature of the disclosure (such as board changes, business updates, or financial results) is not known from this filing text alone. Retail investors should look for the detailed filing or follow-up announcement for specifics.
Without details on what was disclosed, there is no clear near-term impact on shareholders or the stock price. Investors should check the full filing or the company's investor relations page for the specific event being reported.